FF:11417-118F4: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 69: | Line 69: | ||
|sample_ethnicity=U | |sample_ethnicity=U | ||
|sample_experimental_condition= | |sample_experimental_condition= | ||
|sample_gostat=GO:0044464;cell part;0!GO:0005622;intracellular;0!GO:0044424;intracellular part;1.44497142367535e-205!GO:0005737;cytoplasm;4.80266217014246e-197!GO:0043226;organelle;5.7719359400014e-159!GO:0043229;intracellular organelle;9.96804298749472e-159!GO:0043231;intracellular membrane-bound organelle;1.29388345603492e-155!GO:0043227;membrane-bound organelle;2.74141067427318e-155!GO:0044444;cytoplasmic part;3.81356927894189e-143!GO:0044422;organelle part;9.72420601731914e-122!GO:0044446;intracellular organelle part;1.99811356492749e-120!GO:0032991;macromolecular complex;6.71527572585971e-85!GO:0005515;protein binding;5.3140618898694e-84!GO:0030529;ribonucleoprotein complex;3.34920482190612e-77!GO:0044238;primary metabolic process;5.72590738243551e-70!GO:0044237;cellular metabolic process;1.23242879146668e-68!GO:0005739;mitochondrion;2.30624840548005e-64!GO:0043170;macromolecule metabolic process;3.95747951161328e-63!GO:0043233;organelle lumen;3.55313046818924e-61!GO:0031974;membrane-enclosed lumen;3.55313046818924e-61!GO:0003723;RNA binding;1.31467130320536e-54!GO:0031090;organelle membrane;8.73263713071933e-53!GO:0044428;nuclear part;1.34605019556159e-51!GO:0019538;protein metabolic process;4.1192488486392e-51!GO:0005840;ribosome;3.14435872016024e-50!GO:0006412;translation;9.09633598427948e-49!GO:0016043;cellular component organization and biogenesis;1.10336646637808e-46!GO:0044260;cellular macromolecule metabolic process;1.22473749787081e-45!GO:0044267;cellular protein metabolic process;5.30386715035759e-45!GO:0003735;structural constituent of ribosome;1.36682061507713e-44!GO:0009058;biosynthetic process;1.36682061507713e-44!GO:0005634;nucleus;2.07344919303971e-44!GO:0044429;mitochondrial part;5.36259294462607e-42!GO:0043234;protein complex;6.3101706744093e-42!GO:0015031;protein transport;2.15339357699233e-40!GO:0009059;macromolecule biosynthetic process;2.64956992744057e-40!GO:0044249;cellular biosynthetic process;2.82558203781559e-40!GO:0033036;macromolecule localization;1.65762371781485e-39!GO:0006396;RNA processing;9.55802667662657e-38!GO:0033279;ribosomal subunit;1.50432500941205e-37!GO:0045184;establishment of protein localization;1.63271432468958e-37!GO:0008104;protein localization;4.703607775935e-37!GO:0005829;cytosol;6.78963991093144e-37!GO:0031967;organelle envelope;2.0345569282035e-35!GO:0031975;envelope;4.69625237804291e-35!GO:0031981;nuclear lumen;2.90912123349229e-34!GO:0046907;intracellular transport;2.33723995999373e-32!GO:0043283;biopolymer metabolic process;5.47420322077599e-30!GO:0005740;mitochondrial envelope;4.66880011731023e-29!GO:0006996;organelle organization and biogenesis;8.88902165292941e-29!GO:0016071;mRNA metabolic process;9.69858817797068e-29!GO:0031966;mitochondrial membrane;2.08892726741939e-27!GO:0005830;cytosolic ribosome (sensu Eukaryota);2.23133461336247e-27!GO:0019866;organelle inner membrane;3.12005291513627e-27!GO:0008380;RNA splicing;3.18303718366194e-27!GO:0065003;macromolecular complex assembly;6.86320402987171e-27!GO:0006886;intracellular protein transport;2.33379102005075e-26!GO:0010467;gene expression;3.4711716896677e-26!GO:0005743;mitochondrial inner membrane;6.36403455460295e-26!GO:0005783;endoplasmic reticulum;3.65670160771638e-25!GO:0022613;ribonucleoprotein complex biogenesis and assembly;3.93700964423683e-25!GO:0043228;non-membrane-bound organelle;4.31382910777697e-25!GO:0043232;intracellular non-membrane-bound organelle;4.31382910777697e-25!GO:0006397;mRNA processing;3.24225677701248e-24!GO:0022607;cellular component assembly;6.91891627071149e-24!GO:0006119;oxidative phosphorylation;3.16731216352544e-23!GO:0044445;cytosolic part;5.109677664204e-22!GO:0044455;mitochondrial membrane part;5.37616814495044e-22!GO:0012505;endomembrane system;9.84348379723648e-22!GO:0006139;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;4.80875926318139e-21!GO:0015934;large ribosomal subunit;2.2527051687432e-20!GO:0051649;establishment of cellular localization;3.4092829088475e-20!GO:0051641;cellular localization;4.83313888917799e-20!GO:0005654;nucleoplasm;5.63786644313116e-20!GO:0006457;protein folding;2.93879223345501e-19!GO:0005794;Golgi apparatus;2.99667824541595e-19!GO:0044432;endoplasmic reticulum part;3.704557601281e-19!GO:0005681;spliceosome;5.35975174607632e-19!GO:0048770;pigment granule;2.97810321960789e-18!GO:0042470;melanosome;2.97810321960789e-18!GO:0015935;small ribosomal subunit;3.28308525186285e-18!GO:0005746;mitochondrial respiratory chain;1.1390826196762e-17!GO:0016462;pyrophosphatase activity;1.81584771109712e-17!GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;2.06527443926294e-17!GO:0016817;hydrolase activity, acting on acid anhydrides;3.2282503359613e-17!GO:0044451;nucleoplasm part;1.13070089066503e-16!GO:0017111;nucleoside-triphosphatase activity;1.22874779223333e-16!GO:0031980;mitochondrial lumen;4.33178792788963e-16!GO:0005759;mitochondrial matrix;4.33178792788963e-16!GO:0008134;transcription factor binding;7.9061846824569e-16!GO:0051186;cofactor metabolic process;7.93062170488601e-16!GO:0000166;nucleotide binding;8.31394342020534e-16!GO:0016655;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;1.09465154963673e-15!GO:0000502;proteasome complex (sensu Eukaryota);1.85328638418791e-15!GO:0050136;NADH dehydrogenase (quinone) activity;2.00631651604466e-15!GO:0003954;NADH dehydrogenase activity;2.00631651604466e-15!GO:0008137;NADH dehydrogenase (ubiquinone) activity;2.00631651604466e-15!GO:0005730;nucleolus;3.79283268526236e-15!GO:0006259;DNA metabolic process;4.18245450799486e-15!GO:0043285;biopolymer catabolic process;5.87111542551625e-15!GO:0022618;protein-RNA complex assembly;1.06176988952394e-14!GO:0005842;cytosolic large ribosomal subunit (sensu Eukaryota);1.44827423005702e-14!GO:0009057;macromolecule catabolic process;1.60575336392709e-14!GO:0044265;cellular macromolecule catabolic process;2.17853563038446e-14!GO:0012501;programmed cell death;2.2848315079259e-14!GO:0006512;ubiquitin cycle;2.81383793703734e-14!GO:0016874;ligase activity;4.91239416330326e-14!GO:0016192;vesicle-mediated transport;5.64737362176755e-14!GO:0006915;apoptosis;6.04084333368353e-14!GO:0005761;mitochondrial ribosome;7.96796642087022e-14!GO:0000313;organellar ribosome;7.96796642087022e-14!GO:0006605;protein targeting;9.90458247534153e-14!GO:0043412;biopolymer modification;1.23096606245727e-13!GO:0042175;nuclear envelope-endoplasmic reticulum network;1.52832321809634e-13!GO:0051082;unfolded protein binding;1.59092035831771e-13!GO:0008135;translation factor activity, nucleic acid binding;1.72344548061135e-13!GO:0030964;NADH dehydrogenase complex (quinone);1.7401342831355e-13!GO:0045271;respiratory chain complex I;1.7401342831355e-13!GO:0005747;mitochondrial respiratory chain complex I;1.7401342831355e-13!GO:0030163;protein catabolic process;1.8532330572248e-13!GO:0042775;organelle ATP synthesis coupled electron transport;1.88775822399857e-13!GO:0042773;ATP synthesis coupled electron transport;1.88775822399857e-13!GO:0048193;Golgi vesicle transport;1.97603350283137e-13!GO:0005789;endoplasmic reticulum membrane;3.22557348592618e-13!GO:0005843;cytosolic small ribosomal subunit (sensu Eukaryota);3.9573834818168e-13!GO:0048523;negative regulation of cellular process;4.47107337868587e-13!GO:0051603;proteolysis involved in cellular protein catabolic process;5.04432322505569e-13!GO:0006120;mitochondrial electron transport, NADH to ubiquinone;5.61929612809087e-13!GO:0016651;oxidoreductase activity, acting on NADH or NADPH;7.50543389835241e-13!GO:0019941;modification-dependent protein catabolic process;8.28241087858132e-13!GO:0043632;modification-dependent macromolecule catabolic process;8.28241087858132e-13!GO:0044257;cellular protein catabolic process;9.67910415965755e-13!GO:0006464;protein modification process;1.15184375421038e-12!GO:0008219;cell death;1.55815258411158e-12!GO:0016265;death;1.55815258411158e-12!GO:0006732;coenzyme metabolic process;1.60651738495291e-12!GO:0044248;cellular catabolic process;1.72291054220233e-12!GO:0006511;ubiquitin-dependent protein catabolic process;1.81110676406009e-12!GO:0007049;cell cycle;6.97677704452646e-12!GO:0032553;ribonucleotide binding;1.47468667620203e-11!GO:0032555;purine ribonucleotide binding;1.47468667620203e-11!GO:0048519;negative regulation of biological process;1.88485973661117e-11!GO:0005793;ER-Golgi intermediate compartment;2.99937859870139e-11!GO:0009055;electron carrier activity;3.91491026909172e-11!GO:0042254;ribosome biogenesis and assembly;4.21393744400394e-11!GO:0017076;purine nucleotide binding;4.73202469020781e-11!GO:0009259;ribonucleotide metabolic process;1.11075318585524e-10!GO:0046961;hydrogen ion transporting ATPase activity, rotational mechanism;1.24211396909726e-10!GO:0003712;transcription cofactor activity;1.82249736294783e-10!GO:0009150;purine ribonucleotide metabolic process;2.76074271400659e-10!GO:0006163;purine nucleotide metabolic process;3.10995182808454e-10!GO:0000398;nuclear mRNA splicing, via spliceosome;3.36303754580765e-10!GO:0000375;RNA splicing, via transesterification reactions;3.36303754580765e-10!GO:0000377;RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;3.36303754580765e-10!GO:0003743;translation initiation factor activity;5.20969142259442e-10!GO:0003676;nucleic acid binding;8.83594193430668e-10!GO:0043687;post-translational protein modification;1.12139600142241e-09!GO:0046933;hydrogen ion transporting ATP synthase activity, rotational mechanism;1.17595884413105e-09!GO:0009199;ribonucleoside triphosphate metabolic process;1.42549259318432e-09!GO:0003924;GTPase activity;2.01966879168171e-09!GO:0006413;translational initiation;2.04287466084595e-09!GO:0009205;purine ribonucleoside triphosphate metabolic process;2.42927016920658e-09!GO:0009144;purine nucleoside triphosphate metabolic process;2.42927016920658e-09!GO:0009141;nucleoside triphosphate metabolic process;2.85573287940087e-09!GO:0009152;purine ribonucleotide biosynthetic process;2.97079908659675e-09!GO:0006164;purine nucleotide biosynthetic process;3.40900888830579e-09!GO:0009260;ribonucleotide biosynthetic process;3.73839721844898e-09!GO:0043067;regulation of programmed cell death;3.73839721844898e-09!GO:0015986;ATP synthesis coupled proton transport;4.77694073623515e-09!GO:0015985;energy coupled proton transport, down electrochemical gradient;4.77694073623515e-09!GO:0006446;regulation of translational initiation;5.14183228087731e-09!GO:0009142;nucleoside triphosphate biosynthetic process;5.88764384022042e-09!GO:0009201;ribonucleoside triphosphate biosynthetic process;5.88764384022042e-09!GO:0042981;regulation of apoptosis;6.69943728017935e-09!GO:0007005;mitochondrion organization and biogenesis;7.86906157507726e-09!GO:0044431;Golgi apparatus part;7.86906157507726e-09!GO:0022402;cell cycle process;8.26913486554244e-09!GO:0005768;endosome;8.45213217104482e-09!GO:0009206;purine ribonucleoside triphosphate biosynthetic process;9.86267196148948e-09!GO:0009145;purine nucleoside triphosphate biosynthetic process;9.86267196148948e-09!GO:0051246;regulation of protein metabolic process;1.12720753344931e-08!GO:0008639;small protein conjugating enzyme activity;1.19008757254127e-08!GO:0005788;endoplasmic reticulum lumen;1.30570412092331e-08!GO:0006325;establishment and/or maintenance of chromatin architecture;1.5095671315546e-08!GO:0019829;cation-transporting ATPase activity;2.30578480284825e-08!GO:0046034;ATP metabolic process;2.55807297994199e-08!GO:0009056;catabolic process;2.55881047536142e-08!GO:0019787;small conjugating protein ligase activity;2.63990400913852e-08!GO:0004842;ubiquitin-protein ligase activity;2.64348000025953e-08!GO:0006913;nucleocytoplasmic transport;2.65555196482804e-08!GO:0006366;transcription from RNA polymerase II promoter;2.94345088559226e-08!GO:0006399;tRNA metabolic process;2.95508211071195e-08!GO:0043069;negative regulation of programmed cell death;3.36065623009217e-08!GO:0051726;regulation of cell cycle;4.76392232211867e-08!GO:0009060;aerobic respiration;4.78613081644248e-08!GO:0051169;nuclear transport;5.18720412042162e-08!GO:0051188;cofactor biosynthetic process;5.18720412042162e-08!GO:0005524;ATP binding;5.18720412042162e-08!GO:0006323;DNA packaging;5.72527651464998e-08!GO:0000074;regulation of progression through cell cycle;6.00442061647724e-08!GO:0015078;hydrogen ion transmembrane transporter activity;6.11344637827013e-08!GO:0016070;RNA metabolic process;6.57288751827844e-08!GO:0005635;nuclear envelope;6.62925491312252e-08!GO:0016604;nuclear body;6.74890285060045e-08!GO:0016469;proton-transporting two-sector ATPase complex;7.74904606749567e-08!GO:0030120;vesicle coat;7.81579847113803e-08!GO:0030662;coated vesicle membrane;7.81579847113803e-08!GO:0032559;adenyl ribonucleotide binding;7.91323241768918e-08!GO:0016023;cytoplasmic membrane-bound vesicle;7.97339890221736e-08!GO:0006754;ATP biosynthetic process;8.73249872466919e-08!GO:0006753;nucleoside phosphate metabolic process;8.73249872466919e-08!GO:0006461;protein complex assembly;9.4697066365949e-08!GO:0043066;negative regulation of apoptosis;9.76847449427774e-08!GO:0006888;ER to Golgi vesicle-mediated transport;9.95304625838869e-08!GO:0016879;ligase activity, forming carbon-nitrogen bonds;1.05885329455593e-07!GO:0031988;membrane-bound vesicle;1.079889773525e-07!GO:0055086;nucleobase, nucleoside and nucleotide metabolic process;1.12269696678905e-07!GO:0017038;protein import;1.14948599330584e-07!GO:0045333;cellular respiration;1.50557426302104e-07!GO:0008565;protein transporter activity;1.83010582757528e-07!GO:0016881;acid-amino acid ligase activity;1.83010582757528e-07!GO:0000278;mitotic cell cycle;1.83010582757528e-07!GO:0065004;protein-DNA complex assembly;1.97416077969269e-07!GO:0006916;anti-apoptosis;2.563499917358e-07!GO:0030554;adenyl nucleotide binding;2.63369266868684e-07!GO:0006364;rRNA processing;2.97925150055828e-07!GO:0031965;nuclear membrane;2.99912058770359e-07!GO:0016072;rRNA metabolic process;3.81634322724088e-07!GO:0030532;small nuclear ribonucleoprotein complex;4.67674614732345e-07!GO:0051276;chromosome organization and biogenesis;5.25824261934635e-07!GO:0005773;vacuole;5.57719057624957e-07!GO:0003714;transcription corepressor activity;6.72333139089696e-07!GO:0006974;response to DNA damage stimulus;7.55511965704634e-07!GO:0044453;nuclear membrane part;7.72139324556058e-07!GO:0005839;proteasome core complex (sensu Eukaryota);8.13524963341621e-07!GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB cascade;8.18343912784437e-07!GO:0042623;ATPase activity, coupled;8.65195045889813e-07!GO:0043122;regulation of I-kappaB kinase/NF-kappaB cascade;1.00394486951124e-06!GO:0016564;transcription repressor activity;1.00394486951124e-06!GO:0016887;ATPase activity;1.00924412249219e-06!GO:0005525;GTP binding;1.06920780492037e-06!GO:0048475;coated membrane;1.07966749454922e-06!GO:0030117;membrane coat;1.07966749454922e-06!GO:0000139;Golgi membrane;1.13738994520885e-06!GO:0016876;ligase activity, forming aminoacyl-tRNA and related compounds;1.15345625007034e-06!GO:0004812;aminoacyl-tRNA ligase activity;1.15345625007034e-06!GO:0016875;ligase activity, forming carbon-oxygen bonds;1.15345625007034e-06!GO:0009117;nucleotide metabolic process;1.18336676561274e-06!GO:0016491;oxidoreductase activity;1.35312703053093e-06!GO:0006333;chromatin assembly or disassembly;1.35895742523078e-06!GO:0006752;group transfer coenzyme metabolic process;1.37559679405894e-06!GO:0008361;regulation of cell size;1.48285800767381e-06!GO:0016607;nuclear speck;1.73469638596744e-06!GO:0016049;cell growth;1.85309222318421e-06!GO:0043038;amino acid activation;1.89471851089683e-06!GO:0006418;tRNA aminoacylation for protein translation;1.89471851089683e-06!GO:0043039;tRNA aminoacylation;1.89471851089683e-06!GO:0045259;proton-transporting ATP synthase complex;1.89471851089683e-06!GO:0031324;negative regulation of cellular metabolic process;2.08616101484658e-06!GO:0045786;negative regulation of progression through cell cycle;2.94351158756622e-06!GO:0016853;isomerase activity;3.20525339919457e-06!GO:0006099;tricarboxylic acid cycle;3.22696731715324e-06!GO:0046356;acetyl-CoA catabolic process;3.22696731715324e-06!GO:0044440;endosomal part;3.66844904317354e-06!GO:0010008;endosome membrane;3.66844904317354e-06!GO:0005770;late endosome;3.97424317140011e-06!GO:0009108;coenzyme biosynthetic process;3.97515638672521e-06!GO:0016740;transferase activity;4.15872511903835e-06!GO:0001558;regulation of cell growth;4.22889853895284e-06!GO:0050794;regulation of cellular process;4.34049719483132e-06!GO:0031982;vesicle;4.84238663805416e-06!GO:0031410;cytoplasmic vesicle;4.90577497728793e-06!GO:0051187;cofactor catabolic process;5.61863186517409e-06!GO:0065002;intracellular protein transport across a membrane;6.59612821524722e-06!GO:0004298;threonine endopeptidase activity;6.68364629975674e-06!GO:0030036;actin cytoskeleton organization and biogenesis;6.81217002440627e-06!GO:0031252;leading edge;7.03356285175185e-06!GO:0008654;phospholipid biosynthetic process;7.13321653571182e-06!GO:0005905;coated pit;7.36350634961248e-06!GO:0000323;lytic vacuole;7.59262011515274e-06!GO:0005764;lysosome;7.59262011515274e-06!GO:0006334;nucleosome assembly;7.76802679758911e-06!GO:0009109;coenzyme catabolic process;8.32948574081116e-06!GO:0007249;I-kappaB kinase/NF-kappaB cascade;8.41323548038473e-06!GO:0006793;phosphorus metabolic process;8.78723346501346e-06!GO:0006796;phosphate metabolic process;8.78723346501346e-06!GO:0006084;acetyl-CoA metabolic process;9.84723447678972e-06!GO:0015077;monovalent inorganic cation transmembrane transporter activity;1.00181213521493e-05!GO:0032561;guanyl ribonucleotide binding;1.01720840966007e-05!GO:0019001;guanyl nucleotide binding;1.01720840966007e-05!GO:0005667;transcription factor complex;1.0282542465953e-05!GO:0000785;chromatin;1.04742006500206e-05!GO:0032446;protein modification by small protein conjugation;1.14314453190934e-05!GO:0005762;mitochondrial large ribosomal subunit;1.19085333098467e-05!GO:0000315;organellar large ribosomal subunit;1.19085333098467e-05!GO:0045454;cell redox homeostasis;1.33476214539134e-05!GO:0031497;chromatin assembly;1.35927151803861e-05!GO:0051789;response to protein stimulus;1.41470117688155e-05!GO:0006986;response to unfolded protein;1.41470117688155e-05!GO:0005798;Golgi-associated vesicle;1.41780253350104e-05!GO:0016567;protein ubiquitination;1.54519687282434e-05!GO:0009892;negative regulation of metabolic process;1.56698254565922e-05!GO:0016787;hydrolase activity;1.90741908143021e-05!GO:0048522;positive regulation of cellular process;2.33305522776917e-05!GO:0016563;transcription activator activity;2.52712630017418e-05!GO:0030029;actin filament-based process;2.95494714413416e-05!GO:0005694;chromosome;2.98275247423382e-05!GO:0016310;phosphorylation;3.08900543071599e-05!GO:0006281;DNA repair;3.09568010229312e-05!GO:0005643;nuclear pore;4.25144857369523e-05!GO:0033116;ER-Golgi intermediate compartment membrane;4.27056470941519e-05!GO:0044262;cellular carbohydrate metabolic process;4.28840052790268e-05!GO:0009719;response to endogenous stimulus;4.95237727390694e-05!GO:0016591;DNA-directed RNA polymerase II, holoenzyme;5.03874116266949e-05!GO:0006613;cotranslational protein targeting to membrane;5.25970532201841e-05!GO:0016779;nucleotidyltransferase activity;5.53613186722559e-05!GO:0051170;nuclear import;5.53613186722559e-05!GO:0015980;energy derivation by oxidation of organic compounds;5.86814050139835e-05!GO:0000151;ubiquitin ligase complex;6.08128706501982e-05!GO:0016859;cis-trans isomerase activity;6.08128706501982e-05!GO:0030867;rough endoplasmic reticulum membrane;6.13673523041216e-05!GO:0003755;peptidyl-prolyl cis-trans isomerase activity;7.40006769004341e-05!GO:0006260;DNA replication;7.64459418041797e-05!GO:0016568;chromatin modification;7.83406700356796e-05!GO:0006606;protein import into nucleus;7.99283237366069e-05!GO:0000245;spliceosome assembly;8.48166024476697e-05!GO:0003697;single-stranded DNA binding;9.04050074333296e-05!GO:0044427;chromosomal part;9.71478777494714e-05!GO:0016044;membrane organization and biogenesis;9.81767059787107e-05!GO:0046474;glycerophospholipid biosynthetic process;0.000101181991010137!GO:0008092;cytoskeletal protein binding;0.000106818618994516!GO:0008026;ATP-dependent helicase activity;0.000106821763459221!GO:0005769;early endosome;0.000107157722493182!GO:0003713;transcription coactivator activity;0.000125891539812726!GO:0007010;cytoskeleton organization and biogenesis;0.000126724912926364!GO:0042625;ATPase activity, coupled to transmembrane movement of ions;0.000150437377074763!GO:0006091;generation of precursor metabolites and energy;0.000155442377605795!GO:0004386;helicase activity;0.000172154009686612!GO:0040008;regulation of growth;0.000191813555441532!GO:0030176;integral to endoplasmic reticulum membrane;0.000220169614915574!GO:0045934;negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.000227893289351767!GO:0046930;pore complex;0.000234501098468346!GO:0043623;cellular protein complex assembly;0.000237114403291095!GO:0006414;translational elongation;0.000244258463540967!GO:0000087;M phase of mitotic cell cycle;0.000246801422986512!GO:0043566;structure-specific DNA binding;0.000260843188264023!GO:0007067;mitosis;0.000269321485874405!GO:0005753;mitochondrial proton-transporting ATP synthase complex;0.00028202189940245!GO:0007264;small GTPase mediated signal transduction;0.000288314574478079!GO:0050789;regulation of biological process;0.0002981603124007!GO:0005048;signal sequence binding;0.000298458486194883!GO:0008250;oligosaccharyl transferase complex;0.000298784138765749!GO:0005885;Arp2/3 protein complex;0.000355453117095433!GO:0048468;cell development;0.000356714326693874!GO:0019867;outer membrane;0.000360214701394499!GO:0000314;organellar small ribosomal subunit;0.000363766684280291!GO:0005763;mitochondrial small ribosomal subunit;0.000363766684280291!GO:0031968;organelle outer membrane;0.000385716220035207!GO:0016772;transferase activity, transferring phosphorus-containing groups;0.000390135661402068!GO:0046467;membrane lipid biosynthetic process;0.000390465176154699!GO:0006839;mitochondrial transport;0.000396054102828614!GO:0006357;regulation of transcription from RNA polymerase II promoter;0.000416116797819678!GO:0019899;enzyme binding;0.000428137685564241!GO:0043021;ribonucleoprotein binding;0.000429187396327691!GO:0050657;nucleic acid transport;0.000444545832436017!GO:0051236;establishment of RNA localization;0.000444545832436017!GO:0050658;RNA transport;0.000444545832436017!GO:0015405;P-P-bond-hydrolysis-driven transmembrane transporter activity;0.000448814910669564!GO:0015399;primary active transmembrane transporter activity;0.000448814910669564!GO:0006403;RNA localization;0.000450509242008845!GO:0031202;RNA splicing factor activity, transesterification mechanism;0.000456854674613139!GO:0043681;protein import into mitochondrion;0.000473455810518187!GO:0030133;transport vesicle;0.000480160580646461!GO:0003724;RNA helicase activity;0.000501790695555335!GO:0016481;negative regulation of transcription;0.000501790695555335!GO:0015630;microtubule cytoskeleton;0.000509564588012731!GO:0033178;proton-transporting two-sector ATPase complex, catalytic domain;0.000561180617290602!GO:0004579;dolichyl-diphosphooligosaccharide-protein glycotransferase activity;0.000571634473828332!GO:0003899;DNA-directed RNA polymerase activity;0.000571634473828332!GO:0007050;cell cycle arrest;0.000592105166004596!GO:0004576;oligosaccharyl transferase activity;0.000665108287244451!GO:0016706;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors;0.000671498540200496!GO:0022403;cell cycle phase;0.000675405655263921!GO:0043284;biopolymer biosynthetic process;0.000684772777197473!GO:0018196;peptidyl-asparagine modification;0.000731914395829871!GO:0018279;protein amino acid N-linked glycosylation via asparagine;0.000731914395829871!GO:0030663;COPI coated vesicle membrane;0.000763434643652631!GO:0030126;COPI vesicle coat;0.000763434643652631!GO:0046489;phosphoinositide biosynthetic process;0.000766057161927246!GO:0007243;protein kinase cascade;0.000779701148030703!GO:0051427;hormone receptor binding;0.000838738392158738!GO:0016126;sterol biosynthetic process;0.000851653643127542!GO:0007040;lysosome organization and biogenesis;0.000881599584487804!GO:0007006;mitochondrial membrane organization and biogenesis;0.000911760636038474!GO:0030530;heterogeneous nuclear ribonucleoprotein complex;0.000941587131376415!GO:0051920;peroxiredoxin activity;0.000977244434109904!GO:0045261;proton-transporting ATP synthase complex, catalytic core F(1);0.000979302686184981!GO:0006612;protein targeting to membrane;0.000994486558468346!GO:0007033;vacuole organization and biogenesis;0.00105246541260387!GO:0048471;perinuclear region of cytoplasm;0.00105957273927719!GO:0006626;protein targeting to mitochondrion;0.0010597659449731!GO:0009165;nucleotide biosynthetic process;0.00108513917524433!GO:0019843;rRNA binding;0.00114811266429192!GO:0005741;mitochondrial outer membrane;0.00118831340024579!GO:0051301;cell division;0.00119510284532997!GO:0030659;cytoplasmic vesicle membrane;0.00127753292202319!GO:0042802;identical protein binding;0.0012796109849902!GO:0008610;lipid biosynthetic process;0.00128170224351443!GO:0051329;interphase of mitotic cell cycle;0.00153147246750177!GO:0015931;nucleobase, nucleoside, nucleotide and nucleic acid transport;0.00156324879327123!GO:0016679;oxidoreductase activity, acting on diphenols and related substances as donors;0.00159123939826093!GO:0016681;oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor;0.00159123939826093!GO:0008121;ubiquinol-cytochrome-c reductase activity;0.00159123939826093!GO:0035257;nuclear hormone receptor binding;0.00159799334795239!GO:0065009;regulation of a molecular function;0.00160207616115543!GO:0003746;translation elongation factor activity;0.00169283325513166!GO:0048518;positive regulation of biological process;0.00169626035336406!GO:0030137;COPI-coated vesicle;0.00170743584697914!GO:0005791;rough endoplasmic reticulum;0.00175208776878842!GO:0006650;glycerophospholipid metabolic process;0.00179015977579667!GO:0044433;cytoplasmic vesicle part;0.00203679471219425!GO:0005852;eukaryotic translation initiation factor 3 complex;0.00208432124756705!GO:0000786;nucleosome;0.00221797217481894!GO:0005838;proteasome regulatory particle (sensu Eukaryota);0.00228494483642161!GO:0030658;transport vesicle membrane;0.00230588990732713!GO:0030132;clathrin coat of coated pit;0.0023241181735496!GO:0051325;interphase;0.0023519944915371!GO:0006979;response to oxidative stress;0.0024040611276761!GO:0046519;sphingoid metabolic process;0.00247668109039271!GO:0016765;transferase activity, transferring alkyl or aryl (other than methyl) groups;0.0026362775341649!GO:0045263;proton-transporting ATP synthase complex, coupling factor F(o);0.00282879446813419!GO:0033177;proton-transporting two-sector ATPase complex, proton-transporting domain;0.00282879446813419!GO:0043492;ATPase activity, coupled to movement of substances;0.00307175200420131!GO:0031072;heat shock protein binding;0.00328842251429665!GO:0031418;L-ascorbic acid binding;0.00340290156968462!GO:0006891;intra-Golgi vesicle-mediated transport;0.00343211412400761!GO:0006890;retrograde vesicle-mediated transport, Golgi to ER;0.00348405103092258!GO:0008637;apoptotic mitochondrial changes;0.00351880248135791!GO:0006509;membrane protein ectodomain proteolysis;0.00366571995398784!GO:0033619;membrane protein proteolysis;0.00366571995398784!GO:0042626;ATPase activity, coupled to transmembrane movement of substances;0.00372587980297285!GO:0015992;proton transport;0.00374297086361946!GO:0045792;negative regulation of cell size;0.00380721178189891!GO:0008186;RNA-dependent ATPase activity;0.00400941819147757!GO:0031301;integral to organelle membrane;0.00410396224902667!GO:0030308;negative regulation of cell growth;0.00414058231620965!GO:0048487;beta-tubulin binding;0.0041723278693118!GO:0008632;apoptotic program;0.00419019561531347!GO:0008033;tRNA processing;0.00429112100622104!GO:0006818;hydrogen transport;0.00433946464415963!GO:0005774;vacuolar membrane;0.00449904483815704!GO:0045935;positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.0045042108404051!GO:0016197;endosome transport;0.00458976796320892!GO:0045936;negative regulation of phosphate metabolic process;0.00463246316284909!GO:0045893;positive regulation of transcription, DNA-dependent;0.0051028069256309!GO:0045941;positive regulation of transcription;0.00512457219697422!GO:0030880;RNA polymerase complex;0.00520525355938684!GO:0006672;ceramide metabolic process;0.00521341738932213!GO:0031543;peptidyl-proline dioxygenase activity;0.00526704078755084!GO:0016820;hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances;0.00528365456407161!GO:0006383;transcription from RNA polymerase III promoter;0.00530138994454289!GO:0017166;vinculin binding;0.00531576472389256!GO:0043433;negative regulation of transcription factor activity;0.0053615849151527!GO:0051028;mRNA transport;0.00538320318007822!GO:0051101;regulation of DNA binding;0.00548614904427117!GO:0012506;vesicle membrane;0.00551100571716877!GO:0016363;nuclear matrix;0.00556764662169139!GO:0006695;cholesterol biosynthetic process;0.00562437408153417!GO:0006497;protein amino acid lipidation;0.005847351671363!GO:0022890;inorganic cation transmembrane transporter activity;0.00586921383817539!GO:0005813;centrosome;0.00594663451765428!GO:0051087;chaperone binding;0.00645817839336689!GO:0030660;Golgi-associated vesicle membrane;0.0068898599868662!GO:0003729;mRNA binding;0.00694875066738322!GO:0043488;regulation of mRNA stability;0.00694875066738322!GO:0043487;regulation of RNA stability;0.00694875066738322!GO:0046483;heterocycle metabolic process;0.00705420575532606!GO:0005869;dynactin complex;0.00707250054637759!GO:0006897;endocytosis;0.00714643060181905!GO:0010324;membrane invagination;0.00714643060181905!GO:0044452;nucleolar part;0.0072470774086568!GO:0006595;polyamine metabolic process;0.0072470774086568!GO:0017015;regulation of transforming growth factor beta receptor signaling pathway;0.00732608099973047!GO:0006506;GPI anchor biosynthetic process;0.00743929706811444!GO:0048500;signal recognition particle;0.00756505004332117!GO:0016862;intramolecular oxidoreductase activity, interconverting keto- and enol-groups;0.00756505004332117!GO:0000049;tRNA binding;0.00761595535578108!GO:0004177;aminopeptidase activity;0.00769444424283831!GO:0019798;procollagen-proline dioxygenase activity;0.0077043259166257!GO:0000307;cyclin-dependent protein kinase holoenzyme complex;0.0077621247811712!GO:0030027;lamellipodium;0.0077621247811712!GO:0016667;oxidoreductase activity, acting on sulfur group of donors;0.00778222386785575!GO:0006643;membrane lipid metabolic process;0.00816965348641947!GO:0001726;ruffle;0.00827229961861931!GO:0030118;clathrin coat;0.00834887230707214!GO:0000030;mannosyltransferase activity;0.008372174193196!GO:0051098;regulation of binding;0.00854818574242595!GO:0031901;early endosome membrane;0.00868615797367022!GO:0030134;ER to Golgi transport vesicle;0.00876794878948629!GO:0004004;ATP-dependent RNA helicase activity;0.00888730218113631!GO:0051168;nuclear export;0.00906450406214768!GO:0051252;regulation of RNA metabolic process;0.00915911595225619!GO:0006505;GPI anchor metabolic process;0.00925252471821662!GO:0043065;positive regulation of apoptosis;0.00951562543198326!GO:0043068;positive regulation of programmed cell death;0.00960669746426408!GO:0045892;negative regulation of transcription, DNA-dependent;0.00973308663748984!GO:0030127;COPII vesicle coat;0.00990571709280415!GO:0012507;ER to Golgi transport vesicle membrane;0.00990571709280415!GO:0051128;regulation of cellular component organization and biogenesis;0.0105802477110397!GO:0016676;oxidoreductase activity, acting on heme group of donors, oxygen as acceptor;0.0107292836127386!GO:0015002;heme-copper terminal oxidase activity;0.0107292836127386!GO:0016675;oxidoreductase activity, acting on heme group of donors;0.0107292836127386!GO:0004129;cytochrome-c oxidase activity;0.0107292836127386!GO:0031902;late endosome membrane;0.0107552303249725!GO:0055029;nuclear DNA-directed RNA polymerase complex;0.0108999123404261!GO:0000428;DNA-directed RNA polymerase complex;0.0108999123404261!GO:0016281;eukaryotic translation initiation factor 4F complex;0.0112340382143277!GO:0006778;porphyrin metabolic process;0.0112470412179547!GO:0033013;tetrapyrrole metabolic process;0.0112470412179547!GO:0030384;phosphoinositide metabolic process;0.0113777355343072!GO:0033673;negative regulation of kinase activity;0.0114632922519579!GO:0006469;negative regulation of protein kinase activity;0.0114632922519579!GO:0044437;vacuolar part;0.0116679555516726!GO:0006740;NADPH regeneration;0.0117530139876702!GO:0006098;pentose-phosphate shunt;0.0117530139876702!GO:0008047;enzyme activator activity;0.0118044677130961!GO:0008139;nuclear localization sequence binding;0.0122488433012869!GO:0042326;negative regulation of phosphorylation;0.0122488433012869!GO:0016627;oxidoreductase activity, acting on the CH-CH group of donors;0.0122488433012869!GO:0009967;positive regulation of signal transduction;0.012530829051358!GO:0005684;U2-dependent spliceosome;0.0125473492989755!GO:0005815;microtubule organizing center;0.0125911661637644!GO:0005765;lysosomal membrane;0.0126601506065768!GO:0006417;regulation of translation;0.0127631637185677!GO:0008180;signalosome;0.0130687809921368!GO:0043022;ribosome binding;0.0130801894253306!GO:0051348;negative regulation of transferase activity;0.013120797706501!GO:0006402;mRNA catabolic process;0.0131577041606972!GO:0006352;transcription initiation;0.0134350862407522!GO:0045926;negative regulation of growth;0.0137222021267655!GO:0006614;SRP-dependent cotranslational protein targeting to membrane;0.0139376775602972!GO:0045047;protein targeting to ER;0.0139376775602972!GO:0045045;secretory pathway;0.0141542692405464!GO:0016272;prefoldin complex;0.0146456794808593!GO:0005862;muscle thin filament tropomyosin;0.0146899650768909!GO:0042158;lipoprotein biosynthetic process;0.0148170654134205!GO:0030125;clathrin vesicle coat;0.0149994729371931!GO:0030665;clathrin coated vesicle membrane;0.0149994729371931!GO:0030145;manganese ion binding;0.0150919714866748!GO:0048144;fibroblast proliferation;0.0156451108927988!GO:0048145;regulation of fibroblast proliferation;0.0156451108927988!GO:0001836;release of cytochrome c from mitochondria;0.0157002919692731!GO:0006007;glucose catabolic process;0.015857867897638!GO:0031227;intrinsic to endoplasmic reticulum membrane;0.0168740930124878!GO:0003779;actin binding;0.0168740930124878!GO:0015631;tubulin binding;0.01712627548698!GO:0019318;hexose metabolic process;0.0172644051225361!GO:0005975;carbohydrate metabolic process;0.0176232372206171!GO:0000059;protein import into nucleus, docking;0.0177868371025763!GO:0008312;7S RNA binding;0.0183347243408103!GO:0005853;eukaryotic translation elongation factor 1 complex;0.0185580329322498!GO:0005786;signal recognition particle, endoplasmic reticulum targeting;0.0193319033856139!GO:0051287;NAD binding;0.0196618620014877!GO:0003711;transcription elongation regulator activity;0.0201276396722193!GO:0030521;androgen receptor signaling pathway;0.0202611054885585!GO:0030041;actin filament polymerization;0.0202735812203819!GO:0006779;porphyrin biosynthetic process;0.0207515937999623!GO:0033014;tetrapyrrole biosynthetic process;0.0207515937999623!GO:0005832;chaperonin-containing T-complex;0.0211950303438132!GO:0030119;AP-type membrane coat adaptor complex;0.0214997416106305!GO:0031529;ruffle organization and biogenesis;0.0216887571995261!GO:0035258;steroid hormone receptor binding;0.0221641270959822!GO:0006354;RNA elongation;0.0221993386469804!GO:0005996;monosaccharide metabolic process;0.0222538301757902!GO:0050811;GABA receptor binding;0.0223855538973874!GO:0030503;regulation of cell redox homeostasis;0.0227593758643742!GO:0006401;RNA catabolic process;0.0229287794323146!GO:0000082;G1/S transition of mitotic cell cycle;0.0233548297792458!GO:0006950;response to stress;0.0238975033496935!GO:0042168;heme metabolic process;0.0242842237864453!GO:0043161;proteasomal ubiquitin-dependent protein catabolic process;0.0242997265361554!GO:0006984;ER-nuclear signaling pathway;0.0246893988094558!GO:0008287;protein serine/threonine phosphatase complex;0.0248236686157931!GO:0051235;maintenance of localization;0.0250916990010391!GO:0005665;DNA-directed RNA polymerase II, core complex;0.0256245709973988!GO:0003756;protein disulfide isomerase activity;0.025820647626181!GO:0016864;intramolecular oxidoreductase activity, transposing S-S bonds;0.025820647626181!GO:0006289;nucleotide-excision repair;0.0267335663679599!GO:0000209;protein polyubiquitination;0.0267587241970082!GO:0008286;insulin receptor signaling pathway;0.0267587241970082!GO:0019205;nucleobase, nucleoside, nucleotide kinase activity;0.0267587241970082!GO:0008022;protein C-terminus binding;0.0271311246233116!GO:0051270;regulation of cell motility;0.0275561751086658!GO:0006082;organic acid metabolic process;0.0275561751086658!GO:0007265;Ras protein signal transduction;0.0279180196669892!GO:0007034;vacuolar transport;0.027941971207578!GO:0035035;histone acetyltransferase binding;0.0298647366757043!GO:0048146;positive regulation of fibroblast proliferation;0.029924737685188!GO:0008147;structural constituent of bone;0.0301075806088942!GO:0030833;regulation of actin filament polymerization;0.0306692717281382!GO:0009889;regulation of biosynthetic process;0.0306692717281382!GO:0032981;mitochondrial respiratory chain complex I assembly;0.0312078344255666!GO:0010257;NADH dehydrogenase complex assembly;0.0312078344255666!GO:0033108;mitochondrial respiratory chain complex assembly;0.0312078344255666!GO:0019752;carboxylic acid metabolic process;0.0316080533853031!GO:0008538;proteasome activator activity;0.0317123428495105!GO:0030032;lamellipodium biogenesis;0.0320449249388717!GO:0005637;nuclear inner membrane;0.0327560515997358!GO:0031124;mRNA 3'-end processing;0.0330161336878372!GO:0000279;M phase;0.0332767914476061!GO:0030131;clathrin adaptor complex;0.0337433162628969!GO:0006892;post-Golgi vesicle-mediated transport;0.03404905149163!GO:0031326;regulation of cellular biosynthetic process;0.0344694196746655!GO:0030433;ER-associated protein catabolic process;0.0344694196746655!GO:0006515;misfolded or incompletely synthesized protein catabolic process;0.0344694196746655!GO:0032507;maintenance of cellular protein localization;0.0350868542528641!GO:0065007;biological regulation;0.0351660666476426!GO:0005520;insulin-like growth factor binding;0.035614421873242!GO:0016860;intramolecular oxidoreductase activity;0.0367002822582466!GO:0046426;negative regulation of JAK-STAT cascade;0.0367002822582466!GO:0007030;Golgi organization and biogenesis;0.0373799350124759!GO:0008154;actin polymerization and/or depolymerization;0.0374042010795778!GO:0040011;locomotion;0.0376703770797626!GO:0008475;procollagen-lysine 5-dioxygenase activity;0.0376948431042459!GO:0003923;GPI-anchor transamidase activity;0.0377103825129592!GO:0016255;attachment of GPI anchor to protein;0.0377103825129592!GO:0042765;GPI-anchor transamidase complex;0.0377103825129592!GO:0051493;regulation of cytoskeleton organization and biogenesis;0.0381093871488939!GO:0033043;regulation of organelle organization and biogenesis;0.0381093871488939!GO:0033559;unsaturated fatty acid metabolic process;0.0383035186513573!GO:0006636;unsaturated fatty acid biosynthetic process;0.0383035186513573!GO:0030911;TPR domain binding;0.0385757454188769!GO:0051059;NF-kappaB binding;0.0396539774777151!GO:0046822;regulation of nucleocytoplasmic transport;0.0398627174033907!GO:0050178;phenylpyruvate tautomerase activity;0.0402077267963287!GO:0032906;transforming growth factor-beta2 production;0.0402077267963287!GO:0032909;regulation of transforming growth factor-beta2 production;0.0402077267963287!GO:0016584;nucleosome positioning;0.0405619764889807!GO:0006749;glutathione metabolic process;0.0410539970989166!GO:0031300;intrinsic to organelle membrane;0.0412441931684639!GO:0008601;protein phosphatase type 2A regulator activity;0.0412480695180301!GO:0051539;4 iron, 4 sulfur cluster binding;0.0418151012484211!GO:0022408;negative regulation of cell-cell adhesion;0.0418549585901432!GO:0005092;GDP-dissociation inhibitor activity;0.0419594055669632!GO:0004656;procollagen-proline 4-dioxygenase activity;0.0419594055669632!GO:0031545;peptidyl-proline 4-dioxygenase activity;0.0419594055669632!GO:0007162;negative regulation of cell adhesion;0.0431077784947772!GO:0031371;ubiquitin conjugating enzyme complex;0.0433574288933911!GO:0050790;regulation of catalytic activity;0.0438042193321888!GO:0000159;protein phosphatase type 2A complex;0.044161939341205!GO:0030149;sphingolipid catabolic process;0.0443876273888203!GO:0006783;heme biosynthetic process;0.0443876273888203!GO:0006739;NADP metabolic process;0.0443876273888203!GO:0031625;ubiquitin protein ligase binding;0.0452788097759714!GO:0006368;RNA elongation from RNA polymerase II promoter;0.0457556177933783!GO:0005874;microtubule;0.0461539363985643!GO:0006378;mRNA polyadenylation;0.0463887543284139!GO:0006458;'de novo' protein folding;0.0464289952603708!GO:0051084;'de novo' posttranslational protein folding;0.0464289952603708!GO:0001666;response to hypoxia;0.0473080458373473!GO:0000079;regulation of cyclin-dependent protein kinase activity;0.0473272668527835!GO:0004674;protein serine/threonine kinase activity;0.0473438995185981!GO:0030508;thiol-disulfide exchange intermediate activity;0.0476800746091849!GO:0006518;peptide metabolic process;0.0480606544386236!GO:0003690;double-stranded DNA binding;0.0483329666506329!GO:0006644;phospholipid metabolic process;0.0487137923804532!GO:0042771;DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis;0.048964451299531!GO:0051540;metal cluster binding;0.0492455581515116!GO:0051536;iron-sulfur cluster binding;0.0492455581515116!GO:0032940;secretion by cell;0.0492455581515116!GO:0009116;nucleoside metabolic process;0.0492455581515116!GO:0031970;organelle envelope lumen;0.0492455581515116!GO:0031575;G1/S transition checkpoint;0.0492455581515116!GO:0007007;inner mitochondrial membrane organization and biogenesis;0.0495724101423904!GO:0030330;DNA damage response, signal transduction by p53 class mediator;0.0496205768375937 | |||
|sample_id=11417 | |sample_id=11417 | ||
|sample_note= | |sample_note= |
Revision as of 18:15, 25 June 2012
Name: | Fibroblast - Cardiac, donor3 |
---|---|
Species: | Human (Homo sapiens) |
Library ID: | {{{library_id}}} |
Sample type: | {{{sample_category}}} |
Genomic View: | UCSC |
CAGEd-oPOSSUM: | link |
Additional information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample information
RNA information
|
Download raw sequence, BAM & CTSS | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Relative expression to median (log10)
Transcription factors with enriched expression in this sampleRanked list of transcription factor promoter expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed.
Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data
Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data
no result for this sample
TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample
JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs12027
FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs12027
Novel motif | Logo | P-value |
---|---|---|
1 | 1 | 0.989 |
10 | 10 | 0.26 |
100 | 100 | 0.57 |
101 | 101 | 0.297 |
102 | 102 | 0.5 |
103 | 103 | 0.674 |
104 | 104 | 0.43 |
105 | 105 | 0.549 |
106 | 106 | 0.108 |
107 | 107 | 0.0659 |
108 | 108 | 0.148 |
109 | 109 | 0.0586 |
11 | 11 | 0.34 |
110 | 110 | 0.672 |
111 | 111 | 0.743 |
112 | 112 | 0.597 |
113 | 113 | 0.0425 |
114 | 114 | 0.682 |
115 | 115 | 0.00411 |
116 | 116 | 0.106 |
117 | 117 | 0.848 |
118 | 118 | 0.68 |
119 | 119 | 0.643 |
12 | 12 | 0.741 |
120 | 120 | 0.0615 |
121 | 121 | 0.893 |
122 | 122 | 0.333 |
123 | 123 | 8.62972e-4 |
124 | 124 | 0.166 |
125 | 125 | 0.931 |
126 | 126 | 0.925 |
127 | 127 | 0.633 |
128 | 128 | 0.616 |
129 | 129 | 0.748 |
13 | 13 | 0.961 |
130 | 130 | 0.755 |
131 | 131 | 0.455 |
132 | 132 | 0.523 |
133 | 133 | 0.558 |
134 | 134 | 0.567 |
135 | 135 | 0.856 |
136 | 136 | 0.182 |
137 | 137 | 0.0904 |
138 | 138 | 0.445 |
139 | 139 | 0.999 |
14 | 14 | 0.568 |
140 | 140 | 0.497 |
141 | 141 | 0.342 |
142 | 142 | 0.418 |
143 | 143 | 0.0576 |
144 | 144 | 0.745 |
145 | 145 | 0.709 |
146 | 146 | 0.834 |
147 | 147 | 0.143 |
148 | 148 | 0.292 |
149 | 149 | 0.0125 |
15 | 15 | 0.738 |
150 | 150 | 0.0393 |
151 | 151 | 0.955 |
152 | 152 | 0.00532 |
153 | 153 | 0.335 |
154 | 154 | 0.586 |
155 | 155 | 0.31 |
156 | 156 | 0.696 |
157 | 157 | 0.376 |
158 | 158 | 0.038 |
159 | 159 | 0.875 |
16 | 16 | 0.084 |
160 | 160 | 0.334 |
161 | 161 | 0.406 |
162 | 162 | 0.485 |
163 | 163 | 0.812 |
164 | 164 | 0.238 |
165 | 165 | 0.208 |
166 | 166 | 0.717 |
167 | 167 | 0.668 |
168 | 168 | 0.528 |
169 | 169 | 0.0725 |
17 | 17 | 0.35 |
18 | 18 | 0.255 |
19 | 19 | 0.0781 |
2 | 2 | 0.407 |
20 | 20 | 0.592 |
21 | 21 | 0.41 |
22 | 22 | 0.262 |
23 | 23 | 0.787 |
24 | 24 | 0.928 |
25 | 25 | 0.159 |
26 | 26 | 0.556 |
27 | 27 | 0.369 |
28 | 28 | 0.154 |
29 | 29 | 0.465 |
3 | 3 | 0.835 |
30 | 30 | 0.441 |
31 | 31 | 0.283 |
32 | 32 | 6.62059e-15 |
33 | 33 | 0.822 |
34 | 34 | 0.558 |
35 | 35 | 0.529 |
36 | 36 | 0.337 |
37 | 37 | 0.0956 |
38 | 38 | 0.651 |
39 | 39 | 0.563 |
4 | 4 | 0.641 |
40 | 40 | 0.534 |
41 | 41 | 0.766 |
42 | 42 | 0.335 |
43 | 43 | 0.933 |
44 | 44 | 0.134 |
45 | 45 | 0.455 |
46 | 46 | 0.501 |
47 | 47 | 0.857 |
48 | 48 | 0.377 |
49 | 49 | 0.425 |
5 | 5 | 0.773 |
50 | 50 | 0.935 |
51 | 51 | 0.718 |
52 | 52 | 0.911 |
53 | 53 | 0.12 |
54 | 54 | 0.553 |
55 | 55 | 0.417 |
56 | 56 | 0.992 |
57 | 57 | 0.831 |
58 | 58 | 0.105 |
59 | 59 | 0.0421 |
6 | 6 | 0.912 |
60 | 60 | 0.898 |
61 | 61 | 0.778 |
62 | 62 | 0.279 |
63 | 63 | 0.768 |
64 | 64 | 0.766 |
65 | 65 | 0.372 |
66 | 66 | 0.623 |
67 | 67 | 0.839 |
68 | 68 | 0.481 |
69 | 69 | 0.196 |
7 | 7 | 0.326 |
70 | 70 | 0.639 |
71 | 71 | 0.79 |
72 | 72 | 0.357 |
73 | 73 | 0.00116 |
74 | 74 | 0.897 |
75 | 75 | 0.945 |
76 | 76 | 0.357 |
77 | 77 | 0.0155 |
78 | 78 | 0.942 |
79 | 79 | 1.65658e-4 |
8 | 8 | 0.17 |
80 | 80 | 0.631 |
81 | 81 | 0.71 |
82 | 82 | 0.566 |
83 | 83 | 0.128 |
84 | 84 | 0.304 |
85 | 85 | 0.22 |
86 | 86 | 0.858 |
87 | 87 | 0.00583 |
88 | 88 | 0.601 |
89 | 89 | 0.0169 |
9 | 9 | 0.913 |
90 | 90 | 0.0354 |
91 | 91 | 0.704 |
92 | 92 | 0.906 |
93 | 93 | 0.929 |
94 | 94 | 0.715 |
95 | 95 | 0.0914 |
96 | 96 | 0.209 |
97 | 97 | 0.627 |
98 | 98 | 0.335 |
99 | 99 | 0.0201 |
de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br>
library id: CNhs12027
FANTOM5 (FF) ontology
Direct parent terms
is_a relathionship
EFO:0002091 biological replicate
FF:0000002 in vivo cell sample
FF:0000059 human cardiac fibroblast sample
FF:0000210 human sample
Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data
CL: Cell type
0000000 (cell), 0000000 (cell)
0000003 (native cell)
0000055 (non-terminally differentiated cell)
0000723 (somatic stem cell)
0000048 (multi fate stem cell)
0000548 (animal cell)
0000034 (stem cell)
0002320 (connective tissue cell)
0002371 (somatic cell)
0000219 (motile cell)
0000134 (mesenchymal cell)
0000255 (eukaryotic cell)
0002494 (cardiocyte)
0000057 (fibroblast)
0002548 (cardiac fibroblast)
UBERON: Anatomy
0000468 (multi-cellular organism)
0000922 (embryo)
0007100 (primary circulatory organ)
0000948 (heart)
0000483 (epithelium)
0002384 (connective tissue)
0000926 (mesoderm)
0000479 (tissue)
0000062 (organ)
0004111 (anatomical conduit)
0004120 (mesoderm-derived structure)
0000025 (tube)
0000061 (anatomical structure)
0000465 (material anatomical entity)
0000480 (anatomical group)
0000923 (germ layer)
0003914 (epithelial tube)
0002050 (embryonic structure)
0005423 (developing anatomical structure)
0000477 (anatomical cluster)
0000481 (multi-tissue structure)
0000467 (anatomical system)
0001062 (anatomical entity)
0000119 (cell layer)
0003103 (compound organ)
0005291 (embryonic tissue)
0001048 (primordium)
0006598 (presumptive structure)
0002532 (epiblast (generic))
0004535 (cardiovascular system)
0005498 (primitive heart tube)
0003081 (lateral plate mesoderm)
0001009 (circulatory system)
0004140 (primary heart field)
0009881 (anterior lateral plate mesoderm)
0006603 (presumptive mesoderm)
0004141 (heart tube)
0004872 (splanchnic layer of lateral plate mesoderm)
0003084 (heart primordium)
0007005 (cardiac mesoderm)
0004139 (cardiogenic plate)
0004291 (heart rudiment)
FF: FANTOM5
NA
Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA